Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itopride in functional dyspepsia
2005-001282-34Phase 3Completed
- Sponsor
- Axcan Pharma Inc.
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Itax with Placebo (2 arms). Primary endpoints: Change in overall severity of functional dyspepsia using adapted Leeds Dyspepsia Questionnaire, Upper abdominal pain and fullness assessed by Leeds Dyspepsia Questionnaire items and 1 more. Started Apr 2005; status: completed.
02
Drugs
itopride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2005-001282-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001282-34.